SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-17
👔
Forte Biosciences, Inc.
@FBRX_InsiderForm 4 Filing: Riley Antony A Acquires (Grant) shares of $FBRX
STOCK AWARD / GRANT
⚡ MATERIALITY: 2/10
corporate issuer
Forte Biosciences, Inc.
Ticker: $FBRX
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-16
Shares: 22,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Riley Antony A, holds the title of CHIEF FINANCIAL OFFICER at Forte Biosciences, Inc..
On 2026-06-16, the insider transacted 22,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Riley Antony A (CHIEF FINANCIAL OFFICER) was granted $0 of $FBRX
Post-Transaction Position: 22,000 shares
SEC Accession No: 0001339375-26-000008 (CIK: 1339375)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.